Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-384042

Chief Executive Officer sold 19,023 shares at $37.94 ($721,733)

  • Chief Executive Officer acquired 40,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Barrow Robert · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-02 Grant or award : show line 1 in the form 10b5-1 +40,000 1,513,663 D
2026-09-03 Sale : show line 2 in the form 10b5-1 −19,023 $37.94 $721,733 1,494,640 D
Open-market sales · 19,023 sh · avg $37.94 · $721,733
Loading xslF345X06/ownership.xml…